METHOD OF MANUFACTURING DIVISIBLE TABLETS

    公开(公告)号:SK76997A3

    公开(公告)日:1998-02-04

    申请号:SK76997

    申请日:1995-12-22

    Applicant: BASF AG

    Abstract: The present invention concerns a method of producing divisible tablets by melting the mixture containing one or more pharmaceutically active substances and one or more additive substances; and by calendering the melting with two rotating form cylinders with the cavities for suppression and forming the melting to the tablets. Device for suppression and forming of the melting to the tablets comprises at least one form cylinder (6, 8) with cavities (2) divided by at least one ridge (7) which extends as far as the surface line of the cylinder and forms a break groove.

    METHOD FOR PRODUCING SMALL-PARTICLE PREPARATIONS OF BIOLOGICALLY ACTIVE SUBSTANCES

    公开(公告)号:CA2286832C

    公开(公告)日:2006-03-07

    申请号:CA2286832

    申请日:1998-05-13

    Applicant: BASF AG

    Abstract: The invention relates to a method for the continuous production of solid, particle-based preparations of biologically active substances, in which preparations the biologically active substances are homogeneously distributed in a matrix of additives which can be thermoplastically processed, in a screw extruder divided into several zones. Said method is characterized in that the matrix additives are first melted in a healable area and the biologically active components mixed with the matrix additives. Thereafter, the mixture is cooled, pre-crushed and finely ground in a cooling zone. The screw geometry of the cooling zone is designed in such a way that the cooling zone comprises a conveyor zone, a mixing zone and a kneading zone.

    80.
    发明专利
    未知

    公开(公告)号:ES2180738T3

    公开(公告)日:2003-02-16

    申请号:ES96903958

    申请日:1996-02-01

    Applicant: BASF AG

    Abstract: PCT No. PCT/EP96/00417 Sec. 371 Date Jul. 30, 1997 Sec. 102(e) Date Jul. 30, 1997 PCT Filed Feb. 1, 1996 PCT Pub. No. WO96/25151 PCT Pub. Date Aug. 22, 1996Solid preparations are obtainable by melt extrusion of A) at least one active compound, B) a mixture of B1) from 10 to 90% by weight of a water-soluble, thermoplastic polymer, and B2) from 10 to 90% by weight of a low-substituted hydroxypropylcellulose, and C) from 0 to 50% by weight, based on the total amount of the preparation, of customary pharmaceutical auxiliaries.

Patent Agency Ranking